Cargando…
The Use of Fish Oil Lipid Emulsion in the Treatment of Intestinal Failure Associated Liver Disease (IFALD)
Since 2004, fish oil based lipid emulsions have been used in the treatment of intestinal failure associated liver disease, with a noticeable impact on decreasing the incidence of morbidity and mortality of this often fatal condition. With this new therapy, however, different approaches have emerged...
Autores principales: | Chang, Melissa I., Puder, Mark, Gura, Kathleen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546610/ https://www.ncbi.nlm.nih.gov/pubmed/23363993 http://dx.doi.org/10.3390/nu4121828 |
Ejemplares similares
-
Reversal of intestinal failure-associated liver disease (IFALD): emphasis on its multifactorial nature
por: Hvas, Christian, et al.
Publicado: (2016) -
Current Insights Regarding Intestinal Failure-Associated Liver Disease (IFALD): A Narrative Review
por: Zafirovska, Marija, et al.
Publicado: (2023) -
A Metabolomic Analysis of Two Intravenous Lipid Emulsions in a Murine Model
por: Kalish, Brian T., et al.
Publicado: (2013) -
Use of Fish Oil–Based Lipid Emulsions in Infants With Intestinal Failure–Associated Liver Disease: A Case Series
por: St-Jules, David E., et al.
Publicado: (2014) -
IFALD in children: What's new? A narrative review
por: Di Dato, Fabiola, et al.
Publicado: (2022)